India to United States: Fluoxetine Export Trade Route
India has recorded 775 verified shipments of Fluoxetine exported to United States, representing a combined trade value of $143.0M USD. This corridor is served by 23 active Indian exporters, with an average shipment value of $184.5K USD. The leading Indian exporter is SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED, which accounts for 79% of total export value with 52 shipments worth $113.3M USD. On the buying side, AVET PHARMACEUTICALS INC C/O is the largest importer in United States with $112.8M USD in purchases. The top 3 suppliers — SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED, TORRENT PHARMACEUTICALS LTD, AUROBINDO PHARMA LTD — together control 86% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Fluoxetine corridor is one of India's established pharmaceutical export routes, with 775 shipments documented worth a combined $143.0M USD. The route is dominated by SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED, which alone accounts for roughly 79% of all export value, reflecting the consolidated nature of India's fluoxetine manufacturing sector.
Across 23 active suppliers, the average shipment value stands at $184.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with fluoxetine's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 25.5%, placing it at rank #4 among India's top fluoxetine export destinations globally.
On the import side, key buyers of Indian fluoxetine in United States include AVET PHARMACEUTICALS INC C/O, TORRENT PHARMA INC,, J. KNIPPER & COMPANY and 74 others. AVET PHARMACEUTICALS INC C/O is the single largest importer with 16 shipments valued at $112.8M USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ2
- Primary modeSea freight
- Top portMUNDRA SEA
Market Position
- Global rank#4
- Annual growth+25.5%
- Demand growth+23.3%
- Regulatory ease85/100
Top 10 Indian Fluoxetine Exporters to United States
Showing top 10 of 23 Indian suppliers exporting Fluoxetine to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED Avg $2.2M per shipment | 52 | $113.3M | 79.3% |
| 2 | TORRENT PHARMACEUTICALS LTD Avg $258.0K per shipment | 18 | $4.6M | 3.2% |
| 3 | AUROBINDO PHARMA LTD Avg $58.8K per shipment | 77 | $4.5M | 3.2% |
| 4 | ALEMBIC PHARMACEUTICALS LIMITED Avg $20.6K per shipment | 177 | $3.6M | 2.5% |
| 5 | APL HEALTHCARE LIMITED Avg $48.9K per shipment | 73 | $3.6M | 2.5% |
| 6 | MARKSANS PHARMA LIMITED Avg $37.2K per shipment | 75 | $2.8M | 2.0% |
| 7 | DR.REDDY'S LABORATORIES LTD Avg $23.1K per shipment | 87 | $2.0M | 1.4% |
| 8 | DR REDDY S LABORATORIES LIMITED Avg $105.1K per shipment | 12 | $1.3M | 0.9% |
| 9 | DR.REDDY'S LABORATORIES LIMITED Avg $47.4K per shipment | 25 | $1.2M | 0.8% |
| 10 | PAR FORMULATIONS PRIVATE LIMITED Avg $24.9K per shipment | 39 | $970.7K | 0.7% |
This table shows the top 10 of 23 Indian companies exporting fluoxetine to United States, ranked by total trade value. The listed exporters are: SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED, TORRENT PHARMACEUTICALS LTD, AUROBINDO PHARMA LTD, ALEMBIC PHARMACEUTICALS LIMITED, APL HEALTHCARE LIMITED, MARKSANS PHARMA LIMITED, DR.REDDY'S LABORATORIES LTD, DR REDDY S LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LIMITED, PAR FORMULATIONS PRIVATE LIMITED. SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED is the dominant supplier with 52 shipments worth $113.3M USD, giving it a 79% market share. The top 3 suppliers together account for 86% of the total trade value on this route.
Showing top 10 of 23 total Indian exporters on the India to United States Fluoxetine export route.
Top 10 Fluoxetine Importers in United States
Showing top 10 of 77 known buyers in United States receiving Fluoxetine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian fluoxetine in United States include AVET PHARMACEUTICALS INC C/O, TORRENT PHARMA INC,, J. KNIPPER & COMPANY, DR REDDYS LABORATORIES INC, AUROBINDO PHARMA USA INC, among 77 total buyers. The largest importer is AVET PHARMACEUTICALS INC C/O, accounting for $112.8M USD across 16 shipments — representing 79% of all fluoxetine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AVET PHARMACEUTICALS INC C/O | 16 | $112.8M | 78.9% |
| 2 | TORRENT PHARMA INC, | 11 | $4.2M | 3.0% |
| 3 | J. KNIPPER & COMPANY | 99 | $2.0M | 1.4% |
| 4 | DR REDDYS LABORATORIES INC | 28 | $1.9M | 1.3% |
| 5 | AUROBINDO PHARMA USA INC | 17 | $1.5M | 1.1% |
| 6 | AUROLOGISTICS LLC (AUROBINDO PHARMA | 23 | $1.5M | 1.0% |
| 7 | J KNIPPER COMPANY | 46 | $1.4M | 1.0% |
| 8 | XXROBXXDO XXARMXXUSAXX INXX | 20 | $1.1M | 0.8% |
| 9 | AVET PHARMACEUTICALS INC | 48 | $1.1M | 0.8% |
| 10 | TORRENT PHARMA INC | 14 | $1.1M | 0.8% |
Showing top 10 of 77 Fluoxetine importers in United States on this route.
Top 10 Fluoxetine Formulations Imported by United States
Showing top 10 of 454 product formulations shipped on the India to United States Fluoxetine route, ranked by trade value
United States imports a wide range of fluoxetine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — FLUOXETINE CAPSULES USP, 20 MG (PACK 1000S)B/NO.231187 TO 231190 M/D.OCT.2023 E/D.SEP.2025 B/NO.231191 TO 231197 M/D.NO — accounts for $112.7M USD across 1 shipments. There are 454 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FLUOXETINE CAPSULES USP, 20 MG (PACK 1000S)B/NO.231187 TO 231190 M/D.OCT.2023 E/D.SEP.2025 B/NO.231191 TO 231197 M/D.NO | 1 | $112.7M | 78.8% |
| 2 | FLUOXETINE TABLETS USP 10 MG (NDC NO. 13668-443-30) (FLUOXETINE USP 10 MG) (NOS=1X30 TABS W/O CANISTER) | 4 | $1.9M | 1.3% |
| 3 | FLUOXETINE TABLETS USP 20 MG (NDC NO. 13668-473-30) (FLUOXETINE USP 20 MG) (NOS=1X30 TABS W/O CANISTER) | 2 | $1.6M | 1.1% |
| 4 | FLUOXETINE CAPSULES 20MG | 21 | $1.1M | 0.7% |
| 5 | FLUOXETINE CAPSULES 40MG | 12 | $1.0M | 0.7% |
| 6 | 300009183 FLUOXETINE DELAYED-RELEASE CAPSULES USP 90MG 4S (18720 SU X 4=74 880 NOS) | 1 | $637.7K | 0.4% |
| 7 | 300009183 FLUOXETINE DELAYED-RELEASE CAPSULES USP 90MG 4S (18000 SU X 4=72,000 NOS)NOS | 3 | $613.9K | 0.4% |
| 8 | FLUOXETINE ORAL SOLUTION USP 20MG/5ML (FLUOXETINE ORAL SOLUTION USP 20 MG/5 ML)1'S | 7 | $488.3K | 0.3% |
| 9 | FLUOXETINE CAP USP 40 MG_100S_AP_US | 12 | $452.1K | 0.3% |
| 10 | FLUOXETINE DELAYED RELEASE CAPSULES USP90MG 4S (TOTAL QTY PACKS 12708 X 4S=50832 NOS) | 1 | $431.7K | 0.3% |
Showing top 10 of 454 Fluoxetine formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA handles the highest volume with 116 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's fluoxetine exports to United States are driven primarily by a handful of large-scale manufacturers. SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED with 52 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 23 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED, TORRENT PHARMACEUTICALS LTD, AUROBINDO PHARMA LTD — together account for 86% of total trade value on this route. The average shipment value of $184.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as fluoxetine tablets usp 10 mg (ndc no. 13668-443-30) (fluoxetine usp 10 mg) (nos=1x30 tabs w/o canister) and fluoxetine tablets usp 20 mg (ndc no. 13668-473-30) (fluoxetine usp 20 mg) (nos=1x30 tabs w/o canister), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AVET PHARMACEUTICALS INC C/O is the largest importer with 16 shipments worth $112.8M USD — representing 79% of all fluoxetine imports from India on this route. A total of 77 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $143.0M
- Avg. Shipment
- $184.5K
- Suppliers
- 23
- Buyers
- 77
- Transit (Sea)
- ~17 days
- Annual Growth
- +25.5%
Related Analysis
Reverse Direction
United States → India — Fluoxetine (Import)Other Fluoxetine Routes
Unlock the Full India to United States Fluoxetine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 775 shipments on this route.
Frequently Asked Questions — India to United States Fluoxetine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Fluoxetine to United States?
The leading Indian exporters of Fluoxetine to United States are SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED, TORRENT PHARMACEUTICALS LTD, AUROBINDO PHARMA LTD. SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED holds the largest market share at approximately 79% of total trade value on this route.
Q What is the total value of Fluoxetine exports from India to United States?
India exports Fluoxetine to United States worth approximately $143.0M USD across 775 recorded shipments. The average value per shipment is $184.5K USD.
Q Which ports does India use to ship Fluoxetine to United States?
The most active port of origin is MUNDRA SEA with 116 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to United States for Fluoxetine?
The average transit time for Fluoxetine shipments from India to United States is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Fluoxetine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.5% with demand growth tracking at 23.3%. The route is ranked #4 among India's top Fluoxetine export destinations globally.
Q How many suppliers are active on the India to United States Fluoxetine route?
There are currently 23 active Indian suppliers exporting Fluoxetine to United States. The market is moderately concentrated with SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED accounting for 79% of total shipment value.
Q Who are the main importers of Fluoxetine from India in United States?
The leading importers of Indian Fluoxetine in United States include AVET PHARMACEUTICALS INC C/O, TORRENT PHARMA INC,, J. KNIPPER & COMPANY, DR REDDYS LABORATORIES INC, AUROBINDO PHARMA USA INC. AVET PHARMACEUTICALS INC C/O is the largest buyer with 16 shipments worth $112.8M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Fluoxetine.
- 2.Supplier/Buyer Matching: 23 Indian exporters and 77 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 775 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
775 Verified Shipments
23 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists